Gentherm Inc (NASDAQ:THRM) Given Average Recommendation of "Hold" by Brokerages
Gentherm Inc (NASDAQ:THRM) has received a consensus "Hold" rating from seven analysts, with an average 12-month price target of $39.40. Recent analyst actions include downgrades and price target reductions reflecting mixed sentiment following the company's Q4 earnings miss, despite revenue beating estimates. Institutional investors hold approximately 97% of the stock, with several funds increasing their positions.
Gentherm, Inc. Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators
Gentherm, Inc., a small-cap auto components company, has recently had its stock evaluation revised due to mixed performance indicators. The stock price has declined, trading at $27.67, and its performance has lagged behind the S&P 500 across various timeframes, including a significant year-to-date return deficit. Technical indicators show a mixed outlook, with some bullish signals like RSI, alongside bearish trends indicated by MACD, Bollinger Bands, and Dow Theory.
The Vanguard Group lists zero Gentherm holdings (NASDAQ: THRM)
The Vanguard Group has filed an amended Schedule 13G/A, reporting zero beneficial ownership of Gentherm Inc. common stock (THRM). This change is attributed to an internal realignment on January 12, 2026, which led to certain subsidiaries reporting their holdings separately under SEC Release No. 34-39538. The filing clarifies that this re-statement is a procedural change in reporting structure rather than an indication of a new market trade or sale of shares by Vanguard.
Gentherm (THRM) CAO gets stock award, some shares withheld for tax
Gentherm's Chief Accounting Officer, Nicholas Breisacher, received 353 shares of common stock from the vesting of performance-based restricted stock units (PSUs) granted in 2023. These PSUs settled based on adjusted EBITDA and ROIC performance targets. To cover tax obligations, 102 shares were withheld, increasing his direct holdings to 5,789 Gentherm common shares.
Gentherm (THRM) SVP Barbara Runyon nets equity award after PSU vesting
Barbara J. Runyon, SVP and CHRO of Gentherm Inc., received an equity award of 2,121 shares of common stock after performance-based restricted stock units (PSUs) vested. These shares were granted at no cost, and 961 shares were withheld at $28.64 each to cover tax obligations. The PSU payout was determined by the company's adjusted EBITDA and ROIC performance against targets set in 2023.
Gentherm, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Performance Indicators
Gentherm, Inc., a small-cap auto components company, has seen a stock price decline and underperformed the S&P 500 over the past year and year-to-date. Technical indicators present a mixed picture, with bearish signals from MACD and Bollinger Bands balancing bullish RSI trends. The company's current stock price is $27.86, and its negative returns emphasize the need for strategic adjustments to improve its market position.
Gentherm (THRM) SVP Barkas receives 7,665 RSU equity grant in Form 4
Gentherm Inc.'s Senior Vice President, Rafael Barkas, was granted 7,665 Restricted Stock Units (RSUs) under the company's 2023 Equity Incentive Plan. These RSUs will vest in three equal installments on March 17, 2027, March 17, 2028, and March 17, 2029. Following this grant, Barkas directly holds 30,379 shares of Gentherm common stock, with this award serving as compensation rather than an open-market transaction.
Auto comfort tech moves into sofas as Gentherm launches with KUKA
Gentherm (NASDAQ: THRM) has announced its expansion into the home furniture market through a collaboration with KUKA Home in Asia. This partnership will integrate Gentherm's thermal and pneumatic comfort technologies, previously exclusive to the automotive sector, into home furniture products under the co-branded program "Enhanced Comfort by Gentherm." The move demonstrates the scalability of Gentherm's technology into new applications and aligns with the company's recent strategic developments in automotive and medical sectors.
Gentherm (NASDAQ: THRM) revises equity awards, notes Modine deal
Gentherm (NASDAQ: THRM) has updated its 2023 Equity Incentive Plan by revising its restricted stock unit and performance stock unit agreements. These revisions, approved by the Compensation and Talent Committee, include provisions for accelerated vesting in cases of death, disability, certain involuntary terminations, and qualifying retirements. Additionally, the company referenced a planned transaction involving Gentherm, Modine, and Modine’s Performance Technologies business (SpinCo), indicating that relevant SEC filings (Form S-4 and Form 10) will be prepared to provide shareholders with prospectus and proxy information.
Gentherm, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead
Gentherm, Inc. has formed a Death Cross, suggesting a potential bearish trend, even though some technical indicators show mixed signals. The company has significantly underperformed the S&P 500 over the past year, with its stock down 7.77%, and is down 22.93% year-to-date. Investors are advised to monitor these trends due to anticipated volatility.
American Century Companies Inc. Grows Position in Gentherm Inc $THRM
American Century Companies Inc. significantly increased its stake in Gentherm Inc (NASDAQ:THRM) by 36.1% in the third quarter, now owning 513,791 shares valued at $17.5 million. Despite missing EPS estimates, Gentherm exceeded revenue expectations with an 8.5% year-over-year increase. Analysts hold a mixed view on the stock, with an average "Hold" rating and a price target of $40.40, while the stock currently trades around $28.91.
New surgery system to warm and secure patients in one device
Gentherm Medical has appointed KNB Communications as its agency of record to launch the ThermAffyx™ Patient Safety System, a novel device designed to integrate patient warming and securement during surgery. The system has a 510(k) Class II premarket notification submitted to the FDA, with clearance expected in May 2026. KNB Communications will focus on strategic healthcare communications to raise awareness among clinicians, investors, and patients ahead of its commercial rollout.
Gentherm Medical Selects KNB Communications to Amplify News of its Groundbreaking Patient Warming and Securement Device
Gentherm, a global leader in thermal management technologies, has partnered with KNB Communications, a healthcare marketing agency, to promote its new ThermAffyx™ Patient Safety System. This innovative medical device aims to address both patient warming and securement during surgery. FDA clearance for the ThermAffyx™ system is anticipated in May.
Gentherm Medical Selects KNB Communications to Amplify News of its Groundbreaking Patient Warming and Securement Device
Gentherm, a leader in thermal management technologies, has partnered with KNB Communications to launch its new ThermAffyx™ Patient Safety System. This integrated medical device aims to solve both patient warming and securement challenges during surgery. FDA clearance for the device is anticipated in May after Gentherm submitted a 510(k) Class II premarket notification earlier this year.
Gentherm, Inc. Experiences Revision in Stock Evaluation Amidst Market Challenges
Gentherm, Inc., a small-cap company in the Auto Components & Equipment sector, has seen a stock price decline and underperformed the S&P 500 over the past year. Technical indicators for the stock show mixed signals, reflecting ongoing challenges in a competitive market environment. The company's returns over different time frames highlight significant underperformance compared to the S&P 500.
Vanguard Group Inc. Has $112.50 Million Stock Position in Gentherm Inc $THRM
Vanguard Group Inc. reduced its stake in Gentherm Inc. (NASDAQ:THRM) by 1.7% in the third quarter, holding 3,302,983 shares valued at approximately $112.5 million. Despite other institutional investors increasing their positions, Vanguard's move means institutional investors now collectively own about 97.13% of Gentherm. The company reported Q3 EPS of $0.49, missing consensus estimates but revenue beat expectations, rising 8.5% year-over-year.
Segall Bryant & Hamill LLC Purchases 317,246 Shares of Gentherm Inc $THRM
Segall Bryant & Hamill LLC significantly increased its stake in Gentherm Inc (NASDAQ:THRM) by 46.7%, acquiring an additional 317,246 shares, bringing its total holdings to 997,125 shares valued at approximately $33.96 million. This purchase makes the firm own 3.27% of the auto parts company, with institutional investors now holding 97.13% of the stock. Despite Gentherm missing EPS estimates in its most recent quarter, its revenue surpassed expectations, and analysts maintain a "Hold" consensus rating for the company with a target price of $40.40.
Gentherm (THRM) CFO uses 7,757 shares to cover tax withholding
Gentherm Inc.'s CFO and Treasurer, Jonathan C. Douyard, reported a tax-related disposition of 7,757 shares of common stock on February 24, 2026, at a price of $32.51 per share to cover tax withholding obligations. Following this transaction, Douyard directly owns 57,463 shares of the company's common stock. The transaction is classified as an "F" code disposition, indicating it was specifically for tax withholding rather than a discretionary open-market sale.
Gentherm (NASDAQ: THRM) updates credit agreement for Modine transaction
Gentherm Inc. (NASDAQ: THRM) has amended its Second Amended and Restated Credit Agreement to facilitate its proposed transaction with Modine Manufacturing Company and SpinCo. This amendment permits the incurrence of up to $400 million in additional term indebtedness for the transaction and includes other structural adjustments like removing obsolete entities and credit spread adjustments. The company will file Form S-4 and Form 10 with the SEC to provide shareholders with detailed information regarding the merger and spin-off.
Gentherm, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators
Gentherm, Inc., a small-cap auto components company, has seen its stock price decline to $33.00, reflecting an evaluation revision amidst market dynamics. The company has experienced significant volatility with a 52-week high of $39.48 and a low of $22.75. While Gentherm recently outperformed the S&P 500 over the past week, its one-year and three-year returns lag behind the index.
Gentherm, Inc. Experiences Revision in Stock Evaluation Amidst Financial Performance Challenges
Gentherm, Inc. has reported a significant decline in financial performance for the quarter ending December 2025, with pre-tax profit dropping by 51.25% and net profit by 69.23%. Despite a low debt-equity ratio, the company faces operational inefficiencies, low return on capital employed, and lagging stock performance compared to the S&P 500. These challenges highlight the need for a re-evaluation of the auto components and equipment player's stock.
Gentherm Incorporated (NASDAQ:THRM) Q4 2025 Earnings Call Transcript
Gentherm Incorporated (NASDAQ:THRM) reported its Q4 and full-year 2025 earnings, highlighting significant progress in strategic growth beyond automotive into markets like home and office, and medical. The company also discussed its planned combination with Modine Performance Technologies, expected to close by the end of 2026, which will create a $2.6 billion market leader and accelerate Gentherm's growth and market diversification. Gentherm provided revenue guidance for 2026 and a preliminary outlook for 2027, expecting mid-single-digit growth above the automotive market and improved financial performance driven by footprint optimization and new product launches.
Freedom Capital Markets initiates Gentherm stock with buy rating By Investing.com
Freedom Capital Markets initiated coverage on Gentherm Incorporated (NASDAQ:THRM) with a buy rating and a price target of $41.00, citing increased electric vehicle penetration and demand for energy-efficient features. The analyst, Dmitriy Pozdnyakov, noted the company's strong position as an automotive thermal management supplier and expects margin improvements from cost initiatives. Gentherm's current stock price of $30.91 is considered undervalued compared to its InvestingPro Fair Value.
Bastion Asset Management Inc. Sells 111,900 Shares of Gentherm Inc $THRM
Bastion Asset Management Inc. significantly reduced its stake in Gentherm Inc. (NASDAQ:THRM) by selling 111,900 shares, bringing its total holding to 69,619 shares valued at $2.31 million. Other institutional investors have adjusted their positions in Gentherm, with 97.13% of the stock owned by hedge funds and institutions. Gentherm currently holds a consensus "Hold" rating from analysts with a target price of $43.00.
Gentherm (THRM) sees 4.8% passive stake reported by Trigran
Trigran Investments, Inc. and related individuals have reported a 4.8% passive ownership stake in Gentherm Inc. (THRM) through an amended Schedule 13G filing. The group beneficially owns 1,463,143 shares of Gentherm common stock, but explicitly states that the shares were acquired for ordinary business purposes and not to influence control of the company. The filing shows shared voting power over 1,343,432 shares and shared dispositive power over all 1,463,143 shares.
Gentherm Inc (NASDAQ:THRM) Given Consensus Recommendation of "Hold" by Analysts
Analysts have issued a consensus "Hold" rating for Gentherm Inc (NASDAQ:THRM), with five firms providing coverage and an average 12-month price target of $43.00. The stock recently traded around $31.86. Institutional investors hold a significant portion of the company's shares.
Gentherm Announces FDA 510(k) Submission for Innovative Technology Expected to Promote Safer Surgeries and Better Patient Outcomes
Gentherm has submitted a 510(k) Class II premarket notification to the U.S. FDA for its ThermAffyx™ Patient Safety System, an integrated patient warming and securement system. This innovative system aims to address key patient safety concerns during robotic surgery, such as maintaining patient temperature and preventing movement. The company expects FDA clearance within the first half of 2026, with a market launch planned for the third quarter of this year.
Nuance Investments LLC Decreases Stake in Gentherm Inc $THRM
Nuance Investments LLC significantly reduced its stake in Gentherm Inc (NASDAQ:THRM) by 88.3% in the third quarter of 2025, selling 159,709 shares and retaining 21,170 shares. Despite this, other institutions increased their positions, with institutional ownership of Gentherm standing at 97.13%. Analysts currently give Gentherm an average rating of "Moderate Buy" with a target price of $43.00, while the company trades with a market capitalization of $982.74 million and a P/E ratio of 32.20.
Gentherm Submits 510(k) Notification for Innovative ThermAffyx™ Patient Safety System to FDA
Gentherm has submitted a 510(k) Class II premarket notification to the FDA for its ThermAffyx™ Patient Safety System, an integrated patient warming and securement solution for robotic surgeries. This system aims to prevent hypothermia and patient movement, especially in the Trendelenburg position, by leveraging technology adapted from Gentherm's automotive division. FDA clearance is anticipated in the first half of 2026, potentially setting a new standard for patient safety in operating rooms.
Gentherm to Release Fourth Quarter and Year-End 2025 Financial Results on February 19, 2026
Gentherm (NASDAQ: THRM) is scheduled to release its fourth-quarter and year-end 2025 financial results on Thursday, February 19, 2026. The company will host a conference call at 8 AM ET on the same day to discuss these results, providing both toll-free and international dial-in options, along with a live webcast. Gentherm, a leader in thermal management and comfort technologies, reported approximately $1.5 billion in sales for 2024 and secured $2.4 billion in new automotive business awards.
Gentherm to Release Fourth Quarter and Year-End 2025 Financial Results on February 19, 2026
Gentherm will release its financial results for the fourth quarter and full-year 2025 on February 19, 2026, followed by a conference call at 8 AM ET. The company, a global leader in thermal management technologies, secured $2.4 billion in new automotive business awards in 2024 and reported approximately $1.5 billion in sales for the same year. Investors and media can access the webcast and contact information for further details.
Car seat heat tech repurposed to keep surgery patients warm and stable
Gentherm has submitted a 510(k) Class II premarket notification to the FDA for its ThermAffyx Patient Safety System, an integrated patient warming and securement device. This system utilizes thermal technology adapted from Gentherm's automotive division to address intraoperative hypothermia and patient movement during surgeries, particularly those involving Trendelenburg positioning. The company expects FDA clearance in the first half of 2026 and plans a market launch in the third quarter of 2026.
Gentherm Submits 510(k) Notification for Innovative ThermAffyx™ Patient Safety System to FDA
Gentherm has submitted a 510(k) Class II premarket notification to the FDA for its ThermAffyx™ Patient Safety System, an integrated warming and securement solution for robotic surgeries. This system aims to prevent hypothermia and patient movement during procedures, especially in the Trendelenburg position. FDA clearance is anticipated in the first half of 2026, potentially setting a new standard for patient care in operating rooms by adapting proven automotive thermal management technology.
Gentherm Announces FDA 510(k) Submission for Innovative Technology Expected to Promote Safer Surgeries and Better Patient Outcomes
Gentherm has submitted a 510(k) premarket notification to the FDA for its ThermAffyx™ Patient Safety System, an integrated patient warming and securement device. This innovative technology aims to prevent hypothermia and patient movement during robotic surgeries, particularly in the Trendelenburg position. The company anticipates FDA clearance in the first half of 2026, with a market launch planned for the third quarter.
Gentherm Announces FDA 510(k) Submission for Innovative Technology Expected to Promote Safer Surgeries and Better Patient Outcomes
Gentherm has submitted a 510(k) Class II premarket notification to the FDA for its ThermAffyx™ Patient Safety System, an integrated patient warming and securement system. This innovative technology aims to address key safety concerns during robotic surgery, such as maintaining patient temperature and preventing movement, particularly in Trendelenburg positioning. The system, leveraging technology from Gentherm's automotive division, is expected to receive FDA clearance in the first half of 2026, with a market launch planned for the third quarter of this year.
Gentherm (THRM) plans $1B Modine Performance Technologies Reverse Morris Trust merger
Gentherm plans to merge with Modine's Performance Technologies business through a $1 billion Reverse Morris Trust. This deal will create a larger thermal management company with pro forma revenue of approximately $2.6 billion and an expected 13% synergy-adjusted EBITDA margin, while broadening Gentherm’s exposure beyond light vehicles. The merger aims to generate $25 million in annual cost synergies by 2028 and offers significant cross-selling and product integration opportunities, with Gentherm shareholders owning about 60% of the combined company.
DA Davidson reiterates Buy rating on Modine Manufacturing stock with $200 target By Investing.com
DA Davidson has reiterated its Buy rating and a $200 price target for Modine Manufacturing (NYSE:MOD) ahead of its fiscal third-quarter 2026 earnings report. Despite mixed market signals from channel checks, the firm believes its price target model and Modine's performance guidance are appropriately de-risked, supported by Climate Solutions profitability and the Data Center outlook. This comes as Modine has also been in recent news for a merger of its Performance Technologies business with Gentherm and an increase in its revolving credit facility.
Inside the $1 billion deal creating a new thermal management leader
Gentherm is set to merge with Modine’s Performance Technologies unit in a $1 billion Reverse Morris Trust transaction, aiming to create a leading thermal management company with $2.6 billion in pro forma revenue and expected annual cost synergies of $25 million. The deal, anticipated to close in Q4 2026, will result in Gentherm shareholders owning approximately 60% and Modine shareholders 40% of the combined entity. Modine will separate its Performance Technologies business to form a pure-play climate solutions company, focusing on high-growth data center and commercial HVAC markets.
Gentherm (NASDAQ: THRM) to merge with Modine Performance Technologies unit
Gentherm (NASDAQ: THRM) announced its plan to merge with Modine Performance Technologies, a unit of Modine Manufacturing Co., in a Reverse Morris Trust transaction valued at approximately $1 billion. This merger aims to create a larger, more diversified thermal management company with expanded end-market exposure beyond light vehicles, into commercial and heavy-duty equipment and power generation. The combined entity will retain the Gentherm name, headquarters, and NASDAQ listing, with Modine Performance Technologies operating as a division.
Gentherm Incorporated entered into a definitive agreement to acquire Performance Technologies business from Modine Manufacturing Company for approximately $760 million.
Gentherm Incorporated has entered into a definitive agreement to acquire the Performance Technologies business from Modine Manufacturing Company for approximately $760 million. This transaction, structured as a Reverse Morris Trust, is valued at about $1 billion, including Gentherm common stock and a cash distribution to Modine. The merger aims to create a scaled leader in thermal management solutions and is expected to close in Q4 2026, subject to various approvals.
SummerHaven Investment Management LLC Makes New $929,000 Investment in Gentherm Inc $THRM
SummerHaven Investment Management LLC has made a new investment of $929,000 in Gentherm Inc (NASDAQ:THRM), acquiring 27,267 shares in the third quarter. This investment constitutes approximately 0.09% of Gentherm, a company with high institutional ownership. Gentherm currently holds a "Moderate Buy" consensus rating from analysts, with an average price target of $43.00.
Gentherm Inc (NASDAQ:THRM) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Gentherm Inc. (NASDAQ:THRM) has garnered a "Moderate Buy" consensus recommendation from six brokerages, with an average 12-month price target of $43.00. The company recently surpassed quarterly earnings estimates, reporting $0.73 EPS against an expected $0.64, and generated revenue of $386.87 million, a 4.1% year-over-year increase. Analysts anticipate an EPS of approximately $3.10 for the current year, while institutional investors own about 97% of the stock.
SG Americas Securities LLC Grows Stake in Gentherm Inc $THRM
SG Americas Securities LLC significantly increased its stake in Gentherm Inc. by 269.4% in Q3, now owning 37,353 shares valued at $1.27 million. Institutional investors collectively hold about 97.13% of Gentherm's stock. The company reported strong Q3 earnings, beating analyst estimates for both EPS and revenue, contributing to a "Moderate Buy" consensus rating from analysts with a target price of $43.00.
Allspring Global Investments Holdings LLC Boosts Stock Position in Gentherm Inc $THRM
Allspring Global Investments Holdings LLC significantly increased its stake in Gentherm Inc. by 71.2% in the third quarter of 2025, now owning 284,566 shares valued at $9.69 million. This move comes as Gentherm outperformed Q3 earnings and revenue expectations, and analysts maintain a "Moderate Buy" consensus rating with a target price of $43. The company's stock shows strong institutional interest, with nearly 97.13% owned by institutional investors and hedge funds.
Gentherm Inc (NASDAQ:THRM) Given Average Rating of "Moderate Buy" by Analysts
Gentherm Inc (NASDAQ:THRM) has received a "Moderate Buy" consensus rating from six analysts, with an average one-year price target of $43.00. The company saw significant institutional accumulation in Q3, with major investors increasing their holdings. Despite beating Q3 earnings estimates, Gentherm's profitability remains modest, and the stock trades at a P/E of approximately 37.
Gentherm Inc (NASDAQ:THRM) Receives Average Rating of "Moderate Buy" from Brokerages
Gentherm Inc (NASDAQ:THRM) has received an average rating of "Moderate Buy" from six brokerages, with an average 12-month price target of $43.00. The company recently reported strong Q3 earnings, surpassing analyst estimates with EPS of $0.73 and revenue of $386.87 million. Institutional investors hold a significant 97.13% of the stock, with several firms increasing their stakes.
Edenbrook Capital LLC Makes New $2.83 Million Investment in Gentherm Inc $THRM
Edenbrook Capital LLC has made a new $2.83 million investment in Gentherm Inc ($THRM), acquiring 100,034 shares, which now represents its sixth-largest holding. Institutional investors collectively own about 97.13% of Gentherm, and Wall Street analysts maintain a "Moderate Buy" consensus rating with an average price target of $43.00. Gentherm recently exceeded quarterly earnings and revenue estimates.
Gentherm Reports Record Quarterly Revenue of $387 Million and Strategic Growth in Automotive Business
Gentherm achieved record quarterly revenue of $387 million in Q3 2025, driven by strong performance in its automotive division and securing $745 million in new business awards. Despite a slight decrease in gross margin and net income due to higher material costs, the company raised its full-year 2025 revenue guidance to $1.47 billion–$1.49 billion, demonstrating confidence in its strategic growth initiatives. Gentherm continues to expand its market presence, including a new partnership with a global furniture brand for comfort solutions.
Earnings call transcript: Gentherm Q3 2025 boosts revenue outlook
Gentherm reported strong Q3 2025 financial results, with EPS of $0.73, surpassing the forecasted $0.65, and revenue reaching $387 million, exceeding expectations. The company raised its full-year revenue guidance to $1.47-$1.49 billion and highlighted strategic wins in automotive and a new entry into the furniture market, despite a slight aftermarket stock decline. Gentherm's CEO, Bill Presley, emphasized improved execution and progress on long-term strategic initiatives, including expanding into adjacent markets and optimizing operations, while closely monitoring supply chain issues.
Gentherm to Report Third Quarter 2025 Financial Results on October 23, 2025
Gentherm (NASDAQ: THRM) will release its third-quarter 2025 financial results on Thursday, October 23, 2025, and will host a conference call at 8 AM ET to discuss the outcomes. The company, a leader in thermal management and comfort technologies, generated approximately $1.5 billion in sales in 2024 and secured $2.4 billion in automotive new business awards. The announcement highlights potential positives such as strong future sales potential and continuous innovation, while noting the lack of specific financial guidance or product highlights for the upcoming call.
